In global trust barometers, scientists have long featured among the professions most trusted by the public, but pharmaceutical companies remain the least trusted. This is an interesting dichotomy, given that most pharmaceutical employees are scientists. Public trust has been an issue for the pharmaceutical industry for many years, driven principally by a few high-profile examples […]
It’s fair to say 2020 has been an unusual year for many reasons, but if you work in healthcare communications, perhaps one of the more surprising effects of the COVID-19 pandemic has been the unprecedented interest in our field of expertise. Thanks to the recent vaccine data readouts from Pfizer and BioNTech, Moderna and AstraZeneca […]
Every flu season is unpredictable. And while flu activity in the 2020–2021 season appears to be low so far, there may be a rise in influenza cases in the coming months at the same time the US is seeing an unprecedented number of COVID-19 cases. With emergency rooms and hospitals strained to capacity due to […]
World Mental Health Awareness Day falls in October, and there is a growing flurry of activity online each year as individuals, brands and organizations share messages of compassion and support towards smashing the stigma around mental health. Current research shows that employees require more structured support when it comes to their wellbeing, particularly due to […]
Our mental health has taken a beating this year. One of many ripple effects from COVID-19 is the toll that living through a pandemic has taken on people’s emotional, psychological and social wellbeing. Whether it’s stress from the blurring boundaries between work and home life, a sense of longing from not being able to see […]
Many companies, particularly new entrants into the U.S. pharma arena, are facing some level of disruption or impact on their projected timelines for seeking FDA licensure, gathering data from trials for filing, conducting health economics analyses needed to demonstrate improved outcomes, or conducting real-world evidence studies that can help inform medical societies’ deliberations on clinical […]
Clinical trial delays not only impact the current path forward but potentially (depending on the extent of the delay/disruption) can create hurdles for future regulatory filing, approval and launch. Therefore, as with all functions being affected by the pandemic, adaptability will be critical.
Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.
Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.